Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research

Clinical trial NCT06120166 · RECRUITING

Trial details

NCT number: NCT06120166
Sponsor: He Huang
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma

Start date: 2023-11-16
Primary completion: 2025-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.